← Leaderboards
Houda Alachkar
University Of Southern California
$3,800,520
Attributed
$3,800,520
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,800,520 · 3
By mechanism
R01$3,358,116 · 2
R21$442,404 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Andrew Abba Stolz$9,063,253
- Zhang-Xu Liu$3,549,798
- Alan S Yu$15,109,853
- Norah A. Terrault$8,729,722
- Neil Kaplowitz$21,379,778
Others in their field
Other Emerging Leaders on “Sampling”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,167,581
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Scott Topper · Broad Institute, Inc.$77,958,806
- Paul F Gallagher · Woods Hole Oceanographic Institution$63,916,876
- Leonard Freedman · Leidos Biomedical Research, Inc.$60,323,945
- Dale Sandler · Social And Scientific Systems, Inc.$59,740,435
Research focus
SamplingAlgorithmsReceptorImmuneTechnologyT-Cell Receptor RepertoireImmunogenomicsNext Generation SequencingT-LymphocytePredictive ModelingCohortChemotherapyPredictive ToolsMutationCharacteristicsCellsMachine Learning MethodHigh RiskMediatingRegimenCytotoxicCurative TreatmentsDiagnosisAntigen-Specific T Cells
Grant awards (8)
Developing robust and scalable genomics tools and databases to analyze immune receptor repertoires across broad populations$784,171
R01 · FY2025 · AI · contact PI
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia$351,576
R01 · FY2025 · CA · contact PI
Developing robust and scalable genomics tools and databases to analyze immune receptor repertoires across diverse populations$803,971
R01 · FY2024 · AI · contact PI
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia$326,960
R01 · FY2024 · CA · contact PI
Mitochondrial Dysfunction underlies treatment related hepatotoxicity in Hispanics with acute lymphoblastic leukemia$442,404
R21 · FY2023 · CA · contact PI
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia$351,752
R01 · FY2023 · CA · contact PI
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia$360,267
R01 · FY2022 · CA · contact PI
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia$379,419
R01 · FY2021 · CA · contact PI